Related Experiment Video

Updated: Jul 6, 2026

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

Mycoplasma pneumoniae encephalopathy: recovery after intravenous immunoglobulin

Achilleas Attilakos1, Penelope Palaiologou, Evangelia Lagona

  • 1Department of Pediatrics, Athens Medical Center Hospital, Athens, Greece. attilakos@hotmail.com

Pediatric Neurology
|April 16, 2008
PubMed

Insights

Mycoplasma pneumoniae encephalopathy in a child was diagnosed using serology and PCR. Rapid recovery after intravenous immunoglobulin suggests an immune response, highlighting its potential as a treatment.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Mycoplasma pneumoniae is a common pathogen that can cause various extrapulmonary manifestations.
  • Encephalopathy is a serious neurological complication associated with Mycoplasma pneumoniae infection.
  • The exact pathogenesis of Mycoplasma pneumoniae encephalopathy remains incompletely understood, with immune-mediated mechanisms proposed.

Observation:

  • A 7-year-old girl presented with Mycoplasma pneumoniae encephalopathy.
  • The pathogen was identified via serological tests and pharyngeal swab polymerase chain reaction (PCR).
  • Mycoplasma pneumoniae was not detected in the cerebrospinal fluid (CSF).

Findings:

  • The patient exhibited a significant and rapid clinical recovery following administration of intravenous immunoglobulin (IVIG).
  • The absence of pathogen detection in CSF and the swift response to IVIG support an immune-mediated etiology.
  • This case suggests that Mycoplasma pneumoniae encephalopathy may result from an autoimmune process triggered by the infection.

Implications:

  • Intravenous immunoglobulin (IVIG) may be a beneficial therapeutic option for critically ill patients with Mycoplasma pneumoniae encephalopathy.
  • Prompt IVIG treatment can be considered a primary or alternative therapy, particularly when corticosteroid use is contraindicated or uncertain.
  • This approach warrants further investigation in larger studies to establish its efficacy and safety in managing this neurological complication.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...